Article Details

Lonza to establish drug product manufacturing capacity at Chinese facility - BioPharma Reporter

Retrieved on: 2021-08-24 15:10:55

Tags for this article:

Click the tags to see associated articles and topics

Lonza to establish drug product manufacturing capacity at Chinese facility - BioPharma Reporter. View article details on hiswai:

Excerpt

Jeff Li, vice president of commercial development, Lonza, told BioPharma-Reporter: “The installation of the DP manufacturing line marks a significant ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up